Team Clinics Ah Llc Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 508 S Skinner Ave Ste 18, Drumright, OK 74030 Phone: 405-546-4130 |
Drumright Rural Health Clinic Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 612 W Bypass, Drumright, OK 74030 Phone: 918-382-5955 |
Littletree Nurse Practitioner Clinic Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 900 W Bypass, Drumright, OK 74030 Phone: 918-352-9194 |
Drumright Medical Clinic, Pllc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 Lou Allard Dr, Drumright, OK 74030 Phone: 918-352-2555 Fax: 918-352-4709 |
Drumright Community Hospital Llc Family Medicine Medicare: Medicare Enrolled Practice Location: 610 W Bypass, Drumright, OK 74030 Phone: 918-382-2300 |
Drumright Rural Health Clinic Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 612 W. Bypass, Drumright, OK 74030 Phone: 918-382-5955 Fax: 918-382-4709 |
Drumright Healthcare Center Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 900 Ok-33 Truck, Drumright, OK 74030 Phone: 918-701-2302 |
News Archive
Today the U.S. Food and Drug Administration permitted marketing of ClonoSEQ assay, a next generation sequencing-based test for minimal residual disease in patients with acute lymphoblastic leukemiaor multiple myeloma. MRD is a measure of the amount of cancer cells remaining in a person's bone marrow.
Hutchinson-Gilford progeria syndrome is an extremely rare genetic condition that causes premature and accelerated aging.
President Barack Obama is planning to "begin an immediate public relations blitz aimed at turning around Americans' opinion of the health-care bill. … Reshaping the legislation's image will take place in three phases, White House aides said: the immediate aftermath; the seven months until the November midterm elections; and the several years that follow, during which many provisions in the measure will gradually take effect."
According to some estimates, up to one in three people around the world may experience severe anxiety in their lifetime.
New Phase II data presented today at the American Diabetes Association 69th Scientific Sessions in New Orleans show that the investigational type 2 diabetes treatment Syncria (albiglutide) significantly reduced blood glucose levels and provided weight loss across weekly, biweekly and monthly dosing. Reducing blood sugar is a key part of managing type 2 diabetes, a disease that affects over 250 million people worldwide.
› Verified 2 days ago